$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
易瑞沙国内怎么购买?
2025-10-19 11:44:20
Check Details
吉非替尼的价格变化
2025-10-19 11:44:20
Check Details
吉非替尼(易瑞沙)在中国受欢迎的原因
2025-10-19 11:44:20
Check Details
易瑞沙有国产的吗?
2025-10-19 11:44:20
Check Details
肺癌服用易瑞沙一般可以活多久?
2025-10-19 11:44:20
Check Details
肺鳞癌可服用吉非替尼
2025-10-19 11:44:20
Check Details
肺癌分类
2025-10-19 11:44:20
Check Details
阿来替尼对比克唑替尼治疗肺癌的优势
2025-10-19 11:44:20
Check Details
阿来替尼图片及介绍
2025-10-19 11:44:20
Check Details
色瑞替尼对特殊人群有什么限制吗?
2025-10-19 11:44:20
Check Details
阿来替尼能医保吗?
2025-10-19 11:44:20
Check Details
色瑞替尼禁用人群
2025-10-19 11:44:20
Check Details
1
2
...
9152
9153
9154
9155
9156
9157
9158
...
10211
10212
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Complete Guide to Dosage and Dose Adjustment of Entrectinib
2
Comprehensive Analysis of Bleeding Risk with Tepotinib in MET-Mutated Non-Small Cell Lung Cancer
3
Lomustine vs Temozolomide: Comprehensive Comparison of Efficacy and Safety in Glioma Treatment
4
Sopyrronium Bromide (Sofdra) for Hyperhidrosis: Uses, Mechanism and Facial Application Risks
5
Optimal Dosing Time and Medication Principles of Vigabatrin (Sabril)
6
Tepotinib and Osimertinib: Current Status and Clinical Positioning of Combination Therapy in Non-Small Cell Lung Cancer
7
Tumor Shrinkage Effect and Core Therapeutic Value of Pazopanib
8
Cabotegravir Sodium: Pioneering Long-Acting Solution for HIV Treatment and Prevention
9
Tabrecta (Capmatinib): A Targeted Therapy for METex14-Mutated NSCLC
10
Pazopanib Shows Promise as Second-Line Therapy for Aggressive Skin Cancer
11
Opicapone Contraindications: Essential Restrictions for At-Risk Groups
12
Finerenone: An Innovative Treatment for Diabetic Kidney Disease